| 000 | 01610 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515034344.0 | ||
| 264 | 0 | _c20060908 | |
| 008 | 200609s 0 0 eng d | ||
| 022 | _a0091-7451 | ||
| 024 | 7 |
_a10.1101/sqb.2005.70.043 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHaber, D A | |
| 245 | 0 | 0 |
_aMolecular targeted therapy of lung cancer: EGFR mutations and response to EGFR inhibitors. _h[electronic resource] |
| 260 |
_bCold Spring Harbor symposia on quantitative biology _c2005 |
||
| 300 |
_a419-26 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xgenetics |
| 650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGefitinib |
| 650 | 0 | 4 | _aGene Amplification |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aOncogenes |
| 650 | 0 | 4 |
_aQuinazolines _xtherapeutic use |
| 700 | 1 | _aBell, D W | |
| 700 | 1 | _aSordella, R | |
| 700 | 1 | _aKwak, E L | |
| 700 | 1 | _aGodin-Heymann, N | |
| 700 | 1 | _aSharma, S V | |
| 700 | 1 | _aLynch, T J | |
| 700 | 1 | _aSettleman, J | |
| 773 | 0 |
_tCold Spring Harbor symposia on quantitative biology _gvol. 70 _gp. 419-26 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1101/sqb.2005.70.043 _zAvailable from publisher's website |
| 999 |
_c16459056 _d16459056 |
||